Literature DB >> 11162525

Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes.

A Moriuchi1, S Hirono, A Ido, T Ochiai, T Nakama, H Uto, T Hori, K Hayashi, H Tsubouchi.   

Abstract

Several growth factors play an important role in liver regeneration. Once hepatic injury occurs, liver regeneration is stimulated by hepatocyte growth factor (HGF), transforming growth factor (TGF)-alpha, and heparin-binding epidermal growth factor-like growth factor (HB-EGF), whereas TGF-beta1 terminates liver regeneration. In this study, we analyzed the effect of a combination of HGF and epidermal growth factor (EGF) on mitogen-activated protein kinase (MAPK) activity and G1 cyclin expression in primary cultured rat hepatocytes. Treatment with a combination of HGF and EGF, in comparison with that of either HGF or EGF, induced tyrosine phosphorylation of both c-Met and EGF receptor (EGFR) independently and additively stimulated MAPK activity and cyclin D1 expression, resulting in additive stimulation of DNA synthesis. On the other hand, although TGF-beta1 treatment did not affect tyrosine phosphorylation of c-Met and EGFR, MAPK activity, and cyclin D1 expression, which were stimulated by HGF and EGF, DNA synthesis was completely inhibited through a marked decrease in cyclin E expression. These results indicate that potent mitogens, such as HGF, TGF-alpha, and HB-EGF, could induce the additive enhancement of liver regeneration cooperatively through an increase in Ras/MAPK activity followed by cyclin D1 expression, and that TGF-beta1 suppresses the growth factor-induced signals between cyclin D1 and cyclin E, resulting in the inhibition of DNA synthesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162525     DOI: 10.1006/bbrc.2000.4063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic mice.

Authors:  Adam S Jochem; Katie E Holmes; Timothy J Stein
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

2.  SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

Authors:  Q Xie; K D Liu; M Y Hu; K Zhou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.

Authors:  Alyssa R Bonine-Summers; Mary E Aakre; Kimberly A Brown; Carlos L Arteaga; Jennifer A Pietenpol; Harold L Moses; Nikki Cheng
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

4.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

5.  Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation.

Authors:  Aditi Pandya Martin; Anna Miller; Luni Emad; Mohammed Rahmani; Teneille Walker; Clint Mitchell; Michael P Hagan; Margaret A Park; Adly Yacoub; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2008-06-10       Impact factor: 4.436

6.  Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Authors:  Akio Ido; Akihiro Moriuchi; Masatsugu Numata; Toshinori Murayama; Satoshi Teramukai; Hiroyuki Marusawa; Naohisa Yamaji; Hitoshi Setoyama; Il-Deok Kim; Tsutomu Chiba; Shuji Higuchi; Masayuki Yokode; Masanori Fukushima; Akira Shimizu; Hirohito Tsubouchi
Journal:  J Transl Med       Date:  2011-05-08       Impact factor: 5.531

7.  Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway.

Authors:  Insook Yang; Yeri Son; Jae Hoon Shin; Il Yong Kim; Je Kyung Seong
Journal:  BMB Rep       Date:  2022-08       Impact factor: 5.041

8.  Arsenic activates EGFR pathway signaling in the lung.

Authors:  Angeline S Andrew; Rebecca A Mason; Vincent Memoli; Eric J Duell
Journal:  Toxicol Sci       Date:  2009-01-23       Impact factor: 4.849

9.  Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells.

Authors:  Satoshi Koyama; Tomohiro Omura; Atsushi Yonezawa; Satoshi Imai; Shunsaku Nakagawa; Takayuki Nakagawa; Ikuko Yano; Kazuo Matsubara
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.